<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below the note from Amy at Astellas Pharma Canada.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Astellas, through our contact with Amy, is providing PCCN W-W with financial support.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Astellas is the maker of Xtandi, a drug for patients with castrate resistant prostate cancer.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>I recall that we have several members of PCCN W-W who have metastatic PCa.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Please contact Amy, who I have copied on this forwarding of her note, direct at her e-mail address shown below, as I will be away starting mid next week.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>This may prove to be an opportunity to contribute to a PCa pharma understanding PCa patients.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Hayes, Amy [mailto:<span style='background:yellow;mso-highlight:yellow'>amy.hayes@astellas.com</span>] <br><b>Sent:</b> April 5, 2017 1:46 PM<br><b>To:</b> Glen46Nor@gmail.com<br><b>Subject:</b> Metastatic Prostate Cancer Patient<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US>Hello Glen, <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>I hope you are keeping well. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>I am reaching out to you to see if you could help me. Astellas has a national sales meeting around the corner and we aim to have a strong patient focus at the meeting. Our goal is that the whole company will leave the opening plenary feeling a real connection to the patient, which will help remind our employees on the extreme importance of patient centricity. To do this this we would like to have a metastatic prostate cancer patient<span style='color:#1F497D'> </span>address our oncology business unit.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>Do you know anyone in the PCCN group that has metastatic prostate cancer and has the ability to film themselves on an iphone or ipad? Of course, the company we are working with (Bond) will speak to him beforehand and walk him through the best way to record and send the videos. We will provide the patient with 3 questions. His answers will then be edited and worked into a larger video. If possible, we would like to contact the patient by next week. Your help would be truly appreciated. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>Looking forward to hearing from you. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US>Warm regards, <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>Amy<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><b><span lang=EN-US style='font-size:12.0pt'>Amy Hayes<o:p></o:p></span></b></p><p class=MsoNormal><span lang=EN-US>Associate Product Manager, Oncology<span style='color:#1F497D'><br></span>Astellas Pharma Canada<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>675 Cochrane Drive, Suite 500, West Tower | Markham, Ontario | L3R 0B8<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US>Office: 905-940-5779 | Cell: 647-588-5620<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='color:#1F497D'><img width=330 height=82 id="Picture_x0020_4" src="cid:image001.png@01D2AE10.6BF82520" alt="cid:image003.png@01D1C0D9.39578BD0"><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p></div></body></html>